- 1. (Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase
- [A modified form of asparaginase, an anticancer drug that belongs to the family of drugs derived from enzymes. ( NCI )] (UMLS (NCI) C0071568) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme =[AN000] ANTINEOPLASTICS;
ASPARAGINASE;
Glycol, polyethylene;
(Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase =(Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase;
PEGASPARGASE 750 UNT/ML;
| - 51. Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine
- (UMLS (NCI) C1327767) =Therapeutic or Preventive Procedure; ;
|
- 2. 1 month (30 days) post challenge
- (UMLS (HL7) C1547066) =Temporal Concept =Time delay post challenge;
| - 52. Monoclonal Antibody 170
- [A panadenocarcinoma murine monoclonal antibody (MoAB) with potential antineoplastic activity. MoAB m170 recognizes MUC-1 antigen present on the surface of many adenocarcinomas. It may be conjugated with a radioactive element and used in radioimmunotherapy (RIT), a procedure that uses a tumor-specific monoclonal antibody to target radiation to cancer cells. ( NCI )] (UMLS (NCI) C0935746) Monoclonal Antibody m170 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 3. 2 months (60 days) post challenge
- (UMLS (HL7) C1547073) =Temporal Concept =Time delay post challenge;
| - 53. Monoclonal antibody 4B5 anti-idiotype vaccine/Sargramostim
- (UMLS (NCI) C0879388) =Therapeutic or Preventive Procedure
|
- 4. 3 months (90 days) post challenge
- (UMLS (HL7) C1547077) =Temporal Concept =Time delay post challenge;
| - 54. Monoclonal Antibody C-58
- [A human IgM monoclonal antibody (MoAb) directed against a human Cytomegalovirus (CMV) antigen. MoAb C-58 recognizes the p51 protein of viral capsid, thereby might be used for the early detection or treatment of CMV infection. ( NCI )] (UMLS (NCI) C1134662) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 5. Monckeberg Arteriosclerosis
- [Thickening and loss of elasticity of the walls of muscular ARTERIES due to calcification of the TUNICA MEDIA, the concentric layers of helically arranged SMOOTH MUSCLE CELLS. ( MSH )] (UMLS (NCI) C0887866) =Disease or Syndrome
| - 55. Monoclonal Antibody CAL
- [A humanized monoclonal antibody directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL may inhibit cancer-related hypercalcemia. (NCI04) ( NCI )] (UMLS (NCI) C1135160) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 6. Monday
- (UMLS (NCI) C0585024) =Temporal Concept =Days of the week;
| - 56. Monoclonal antibody Ch14.18/Sargramostim
- (UMLS (NCI) C0935879) =Therapeutic or Preventive Procedure
|
- 7. monensin
- [polyether ionophore produced by Streptomyces cinnamonensis; causes collapse of sodium and potassium gradients at the plasma membrane, blocks intracelluar protein transport, and has broad antimicrobial efficacy; also has vasodilatory-antihypertensive properties. ( CSP )] (UMLS (CSP) C0026408) =Organic Chemical; Antibiotic =antifungal antibiotic;
Antiprotozoal Agent;
ionophore;
spirane | - 57. Monoclonal Antibody GD2 Anti-Idiotype Vaccine
- [A class of vaccines that consist of anti-idiotype monoclonal antibodies against the tumor-associated antigen disialoganglioside GD2 with potential antineoplastic activity. Vaccination with a monoclonal antibody GD2 anti-idiotype vaccine produces an immunoglobulin response against GD2 with subsequent destruction of GD2 positive tumor cells via antibody-dependent cellular cytotoxicity (ADCC). GD2 is overexpressed in melanoma, neuroblastoma, soft tissue sarcoma, and small cell carcinoma of the lung. (NCI04) ( NCI )] (UMLS (NCI) C1328690) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 8. Monera
- [free living, parasitic, prokaryotic cells with outer cell wall, inner plasma membrane, and ribosomes, but lacking membranous organelles; about 2500 known species. ( CSP )] (UMLS (CSP) C0596971) =Organism =microorganism;
=Archaea;
bacteria;
blue green algae;
| - 58. Monoclonal Antibody huJ591
- [A humanized monoclonal antibody (MoAb) against the external domain of the Prostate-specific membrane antigen (PSMA), overexpressed in malignant prostate and its metastases. Although PSMA is not a biomarker of disease progression, but over-expression indicates an aggressive phenotype of the prostate cancer. This humanized J591 (huJ591) MoAb was generated by replacing murine Ig sequences with human ones, thereby it can be administered to patients on multiple occasions over long time periods without inducing an immune response. Radiolabelled MoAb huJ591 may be used in immunotherapy of prostate cancer. ( NCI )] (UMLS (NCI) C1134478) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 9. Monetary Amount
- (UMLS (HL7) C1552683) =Quantitative Concept =Quantity;
| - 59. Monoclonal Antibody MDX-060
- [A monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin's disease and other lymphomas, and other cancers. (NCI04) ( NCI )] (UMLS (NCI) C1327954) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 10. Money
- (UMLS (HL7) C1547369) =Idea or Concept =Data type;
◊ (UMLS (HL7) C1548312) Idea or Concept Value type; | - 60. Monoclonal Antibody Mik-Beta-1
- [A murine monoclonal antibody directed against the beta subunit of interleukin-2 receptor (IL-2R), expressed on resting T-lymphocytes, natural killer (NK) cells, and some leukemic cell types. Monoclonal antibody Mik-Beta-1 prevents the binding of IL-2 to IL-2R beta, thereby inhibiting the IL-2-mediated proliferation and activation of T-cells. (NCI04) ( NCI )] (UMLS (NCI) C1134607) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 11. Money and charge code
- (UMLS (HL7) C1547370) =Intellectual Product =Data type;
| - 61. monoclonal antibody production
- [ ] (UMLS (CSP) C1328929) =Research Activity; ;
|
- 12. Money or percentage
- (UMLS (HL7) C1547371) =Intellectual Product =Data type;
| - 62. monoclonal antibody therapy
- [ ] (UMLS (CSP) C0279694) =Therapeutic or Preventive Procedure
|
- 13. Money or percentage indicator
- (UMLS (HL7) C1550422) =Quantitative Concept =HL7 Vocabulary Version 2.5;
=Currency amount;
Percentage | - 63. Monoclonal Gammopathy
- (UMLS (NCI) C1136085) =Neoplastic Process ;
|
- 14. monilial vaginitis
- [ ] (UMLS (CSP) C0006852) =Disease or Syndrome
| - 64. Monoclonal Hypergammaglobulinemia
- (UMLS (NCI) C0920101) =Disease or Syndrome
|
- 15. Moniliales
- [ ] (UMLS (CSP) C0026416) =Fungus ;
=Deuteromycetes;
=Fusarium | - 65. Monoclonal Polymorphic Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1334796) =Neoplastic Process
|
- 16. Moniliasis/candida (excluding X72 Y75)
- (UMLS (ICPC) C0497385) (Moniliasis/candida (excluding X72 Y75); MONILIASIA/ KANDIDOSIA( ESKL. UROGENITALA); Candidiasis/moniliasis (ex X72 Y75); Moniliasis/candidiasis(ex X72 Y75); HIIVASIENI-INFEKTIO (PL X72 Y75); Moniliase/candidose (SF X72 Y75); Soor/Candidiasis (ex X72 Y75); kandida; moniliasis/candida (kiv.X72,Y75); Moniliasi/candidosi(escl X72 Y75); CANDIDA/MONILIASIS-INFEKSJON; Moniliase/candida (excl X72 Y75) ; Candidiasis (ex X72 Y75); MONILIASIS/CANDIDA (EXKL X72 Y75)) Moniliasis/candida (excl X72 Y75); Moniliasis/candida =Disease or Syndrome ;
=Diagnosis/Diseases Component; Integument | - 66. monocrotaline
- [A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment. ( MSH )] (UMLS (CSP) C0085241) =Organic Chemical; Hazardous or Poisonous Substance ;
=alkaloid;
|
- 17. Moniliformis
- [A genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa. ( MSH )] (UMLS (CSP) C0026423) =Invertebrate ;
| - 67. Monoctanoin
- (UMLS (NCI) C0066770) =Lipid; Pharmacologic Substance =glyceride;
Monoctanoin;
[GA900] GASTRIC MEDICATIONS, OTHER;
TO BE DELETED INGREDIENT PREPARATIONS =Monoctanoin;
MONOCTANOIN SOLUTION;
|
- 18. Monitor
- [any instrument that periodically measures or regulates a condition in a system that need to be maintained within prescribed limits. ( CSP )] (UMLS (NCI) C0596972) =Medical Device =biomedical automation;
=telemetry;
patient monitoring device | - 68. MONOCULAR ESOTROPIA
- (UMLS (ICD9CM) C0152204) =Disease or Syndrome ;
|
- 19. Monitoring
- [The act of observing something (and sometimes keeping a record of it). ( NCI )] (UMLS (NCI) C0150369) =Health Care Activity
| - 69. MONOCULAR EXOTROPIA
- [ ] (UMLS (ICD9CM) C0152206) =Disease or Syndrome ;
|
- 20. Monitoring of cardiac output by other technique
- [ ] (UMLS (ICD9CM) C0199627) =Diagnostic Procedure
| - 70. Monocyte
- [large, phagocytic mononuclear leukocytes produced in the vertebrate bone marrow and released into the blood and tissues where they develop into macrophages; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. ( CSP )] (UMLS (NCI) C0026473) =Cell ;
=leukocyte;
|
- 21. monitoring program
- [An officially or unofficially instituted program to track acts of a particular type or categorization. ( HL7V3.0 )] (UMLS (HL7) C1553495) =Idea or Concept =act;
| - 71. Monocyte, Activated Killer
- [Monocytes made cytotoxic by ex vivo incubation with cytokines, especially interferon-gamma. AKM cells are used for adoptive immunotherapy in cancer patients. (MeSH) ( NCI )] (UMLS (NCI) C0079852) =Cell
|
- 22. monkey
- [Any haplorhine primate not belonging to the family Tarsiidae, Hylobatidae, Pongidae, or Hominidae; this does not correspond to any taxon. This group is divided into Old World monkeys (Cercopithecidae) and New World monkeys (Callitrichidae and Cebidae). Many types are used as an experimental model for human disease and drug testing. ( NCI )] (UMLS (CSP) C0026447) =Mammal ;
| - 72. Monocytic Leukemia
- (UMLS (NCI) C0598894) =Neoplastic Process ;
|
- 23. monkeypox virus
- [A species of ORTHOPOXVIRUS causing an epidemic disease among captive primates. ( MSH )] (UMLS (CSP) C0026432) =Virus ;
| - 73. Monocytic Leukemia (in Remission)
- (UMLS (NCI) C0686595) =Neoplastic Process
|
- 24. Mono
- (UMLS (HL7) C1551969) Paviotso;
=Language =WesternNumic;
| - 74. Monocytic leukemia, subacute
- (UMLS (ICD9CM) C0152275) =Neoplastic Process ;
|
- 25. MONO
- [The determination of the number of monocytes in a blood sample. ( NCI )] (UMLS (NCI) C0200637) =Laboratory Procedure
| - 75. Monocytoid B-Cell Lymphoma
- [A primary nodal B-cell non-Hodgkin lymphoma which morphologically resembles lymph nodes involved by marginal zone lymphomas of extranodal or splenic types, but without evidence of extranodal or splenic disease. This is a rare entity, and most patients present with localized or generalized lymphadenopathy. The clinical course is indolent. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0855139) Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 26. MONO dgA RFB4
- [An immunotoxin of monoclonal antibody (MoAb) RFB4 covalently linked to a single deglycosylated ricin toxin A-chain (dgA), originated from castor bean. MoAb RFB4 recognizes CD22 antigen, a B-cell adhesion protein expressed on malignant cells in about 70 percent of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Ricin toxin A-chain, a potent protein synthesis inhibitor, was deglycosylated and was used in this immunoconjugate to avoid hepatic entrapment. This agent limits specific cytotoxicity of ricin toxin to CD22-positive malignant cells. ( NCI )] (UMLS (NCI) C0935906) Monoclonal Antibody Mono-dgA-RFB4;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 76. Monocytosis
- (UMLS (NCI) C0085702) =Finding
|
- 27. monoamine
- [ ] (UMLS (CSP) C0599682) =Organic Chemical ;
| - 77. Monocytosis (symptomatic)
- [ ] (UMLS (ICD9CM) C1719340) MONOCYTOSIS-SYMPTOMATIC =Disease or Syndrome
|
- 28. MONOART JUV RHEUM ARTHR
- [ ] (UMLS (ICD9CM) C0157918) =Disease or Syndrome
| - 78. Monodermal Teratoma
- (UMLS (NCI) C1302569) Ovarian Monodermal Teratoma =Neoplastic Process ;
|
- 29. MONOARTHRIT NOS-FOREARM
- [ ] (UMLS (ICD9CM) C0409230) =Disease or Syndrome
| - 79. MONOFIXATION SYNDROME
- [ ] (UMLS (ICD9CM) C0339611) =Disease or Syndrome
|
- 30. MONOARTHRIT NOS-OTH SITE
- [ ] (UMLS (ICD9CM) C0409225) =Disease or Syndrome
| - 80. monograph
- [essay or treatise on one subject. ( CSP )] (UMLS (CSP) C0282448) =Intellectual Product ;
=Literature;
|
- 31. MONOARTHRITIS NOS-ANKLE
- [ ] (UMLS (ICD9CM) C0409226) =Disease or Syndrome
| - 81. monokine
- [general term for soluble mediators of immune responses that are not antibodies or complement components and that are produced by mononuclear phagocytes (monocytes or macrophages). ( CSP )] (UMLS (CSP) C0026484) =Immunologic Factor ;
=Cytokine;
=cachectin |
- 32. MONOARTHRITIS NOS-HAND
- [ ] (UMLS (ICD9CM) C0409229) =Disease or Syndrome
| - 82. monokine receptor
- [ ] (UMLS (CSP) C0598265) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
|
- 33. MONOARTHRITIS NOS-L/LEG
- [ ] (UMLS (ICD9CM) C0409227) =Disease or Syndrome
| - 83. monolayer
- [ ] (UMLS (CSP) C0872351) =Clinical Drug
|
- 34. MONOARTHRITIS NOS-PELVIS
- [ ] (UMLS (ICD9CM) C0409228) =Disease or Syndrome
| - 84. monomer
- [relatively simple compound, usually containing carbon, that is able to combine in chains with other like or unlike molecules to produce large polymers. ( CSP )] (UMLS (CSP) C0596973) =Chemical Viewed Structurally =chemical structure;
|
- 35. MONOARTHRITIS NOS-SHLDER
- [ ] (UMLS (ICD9CM) C0409232) =Disease or Syndrome
| - 85. Monomorphic Adenoma of Oral Cavity
- (UMLS (NCI) C1335121) Monomorphic Adenoma of the Oral Cavity;
Oral Cavity Monomorphic Adenoma;
=Neoplastic Process ;
|
- 36. MONOARTHRITIS NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0158026) =Disease or Syndrome
| - 86. Monomorphic Adenoma of Parotid
- (UMLS (NCI) C1335362) Monomorphic Adenoma of Parotid Gland;
Monomorphic Adenoma of the Parotid;
Monomorphic Adenoma of the Parotid Gland;
Parotid Gland Monomorphic Adenoma;
Parotid Monomorphic Adenoma =Neoplastic Process ;
|
- 37. MONOARTHRITIS NOS-UP/ARM
- [ ] (UMLS (ICD9CM) C0409231) =Disease or Syndrome
| - 87. Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1334797) Monomorphic B-Cell PTLD;
=Neoplastic Process |
- 38. Monoblast
- [A cell derived from a myeloid progenitor cell. It differentiates into a promonocyte. It is about 12 to 20 micrometer in diameter, has a round to oval nucleus with fine, lightly dispersed chromatin and one to four nucleoli. The cytoplasm is agranular, stains moderately to lightly basophilic, and often has an intensely stained periphery and a prominent perinuclear zone. Monoblasts are found in bone marrow and never appear in the normal peripheral blood. ( NCI )] (UMLS (NCI) C0229655) =Cell ;
| - 88. Monomorphic Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1334798) Monomorphic PTLD;
=Neoplastic Process |
- 39. Monoblastic Sarcoma
- [A less common form of myeloid sarcoma composed of monoblasts. Monoblastic sarcoma may precede or occur simultaneously with acute monoblastic leukemia. (WHO 2001). —2003 ( NCI )] (UMLS (NCI) C1334793) =Neoplastic Process
| - 89. Monomorphic T-Cell Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1334799) Monomorphic T-Cell PTLD;
=Neoplastic Process |
- 40. Monoblasts 20 Percent or More of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334794) Monoblasts 20% or More of Bone Marrow Nucleated Cells;
=Laboratory or Test Result | - 90. Monomorphic Ventricular Tachycardia
- [A ventricular tachycardia in which the ventricular activation sequence is constant. The morphology of the electrocardiographic waveform is unchanging and is referred to as monomorphic. ( NCI )] (UMLS (NCI) C0344431) =Disease or Syndrome ;
|
- 41. Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells
- (UMLS (NCI) C1334795) Monoblasts 80% or More of Bone Marrow Monocytic Cells;
=Laboratory or Test Result | - 91. Mononegavirales
- [eukaryotic viruses possessing linear non-segmented negative strand RNA genomes. ( CSP )] (UMLS (CSP) C0206531) =Virus ;
=RNA virus;
=Ebola virus;
Marburg virus;
Paramyxoviridae;
bullet shaped virus group;
|
- 42. MONOC ESOTROP W A PATTRN
- [ ] (UMLS (ICD9CM) C0155322) =Disease or Syndrome
| - 92. MONONEURITIS ARM NEC
- [ ] (UMLS (ICD9CM) C0154745) =Disease or Syndrome
|
- 43. MONOC ESOTROP W V PATTRN
- [ ] (UMLS (ICD9CM) C0155323) =Disease or Syndrome
| - 93. MONONEURITIS ARM NOS
- [ ] (UMLS (ICD9CM) C0154746) =Disease or Syndrome
|
- 44. MONOC ESOTROP W X/Y PAT
- [ ] (UMLS (ICD9CM) C0155324) =Disease or Syndrome
| - 94. MONONEURITIS LEG NOS
- [ ] (UMLS (ICD9CM) C0154747) =Disease or Syndrome
|
- 45. MONOC EXOTROP W A PATTRN
- [ ] (UMLS (ICD9CM) C0155328) =Disease or Syndrome
| - 95. MONONEURITIS MULTIPLEX
- [WHAT: Mononeuritis multiplex. ( AIR )] (UMLS (ICD9CM) C0151295) =Disease or Syndrome ;
|
- 46. MONOC EXOTROP W V PATTRN
- [ ] (UMLS (ICD9CM) C0155329) =Disease or Syndrome
| - 96. MONONEURITIS NOS
- [ ] (UMLS (ICD9CM) C0235880) =Disease or Syndrome
|
- 47. MONOC EXOTROP W X/Y PAT
- [ ] (UMLS (ICD9CM) C0155330) =Disease or Syndrome
| - 97. Mononeuritis of upper limb and mononeuritis multiplex
- [ ] (UMLS (ICD9CM) C0154741) =Disease or Syndrome
|
- 48. MONOCLON PARAPROTEINEMIA
- (UMLS (ICD9CM) C0026471) =Neoplastic Process ;
| - 98. Monophasic
- [Occurring in or characterised by only one phase or stage. ( NCI )] (UMLS (NCI) C0205186) =Temporal Concept
|
- 49. Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
- [A cancer vaccine consisting of a humanized monoclonal antibody that mimics a tumor-associated antigen 791Tgp72 (also known as CD55). Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing CD55, resulting in tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C1134469) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 99. Monophasic Pattern
- (UMLS (NCI) C1334800) =Finding ;
|
- 50. Monoclonal antibody 11D10 anti-idiotype vaccine/Monoclonal antibody 3H1 anti-idiotype vaccine
- (UMLS (NCI) C0935721) =Therapeutic or Preventive Procedure
| - 100. Monophasic Sarcoma of Synovium
- [A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only. ( NCI )] (UMLS (NCI) C1334801) Monophasic Sarcoma of the Synovium;
Monophasic Synovial Sarcoma =Neoplastic Process ;
|
home
